Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases.
Journal: Cancers
Published: January 19, 2023
Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases.
Journal: Scientific reports
Published: January 19, 2022
Author Correction: Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases.
Journal: Scientific reports
Published: September 09, 2021
Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases.
Journal: Scientific reports
Published: May 19, 2021
Neutrophil to lymphocyte ratio influences impact of steroids on efficacy of immune checkpoint inhibitors in lung cancer brain metastases.
Journal: Scientific reports
Published: September 09, 2020
Optimal management of atypical hemolytic uremic disease: challenges and solutions.
Journal: International journal of nephrology and renovascular disease
Published: May 11, 2019
Anemia from A to zinc: Hypocupremia in the setting of gastric bypass and zinc excess.
Journal: Clinical case reports
Published: March 25, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026